Details for New Drug Application (NDA): 212363
✉ Email this page to a colleague
The generic ingredient in ALLOPURINOL SODIUM is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 212363
Tradename: | ALLOPURINOL SODIUM |
Applicant: | Gland Pharma Ltd |
Ingredient: | allopurinol sodium |
Patents: | 0 |
Pharmacology for NDA: 212363
Mechanism of Action | Xanthine Oxidase Inhibitors |
Suppliers and Packaging for NDA: 212363
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALLOPURINOL SODIUM | allopurinol sodium | INJECTABLE;INJECTION | 212363 | ANDA | Fresenius Kabi USA, LLC | 65219-380 | 65219-380-30 | 1 VIAL, GLASS in 1 CARTON (65219-380-30) / 25 mL in 1 VIAL, GLASS |
ALLOPURINOL SODIUM | allopurinol sodium | INJECTABLE;INJECTION | 212363 | ANDA | Gland Pharma Limited | 68083-380 | 68083-380-01 | 1 VIAL, GLASS in 1 CARTON (68083-380-01) / 25 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Jan 26, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription